speb/financial-data huggingface dataset:
BAYA balance_sheet (annual, 2025-12-31) — Capital Stock: 11761163.00
BAYA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 11761163.00
BAYA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 44129.00
BAYA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 44129.00
BAYA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 44129.00
BAYA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 44129.00
BAYA balance_sheet (annual, 2025-12-31) — Cash Financial: 44129.00
BAYA balance_sheet (quarterly, 2025-12-31) — Cash Financial: 44129.00
BAYA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -29008157.00
BAYA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -8206656.00
BAYA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 29008157.00
BAYA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 8206656.00
BAYA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -49491.00
BAYA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 5787.00
BAYA cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 208043.00
BAYA cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -407295.00
BAYA cash_flow (annual, 2025-12-31) — Change In Payable: 703183.00
BAYA cash_flow (quarterly, 2025-12-31) — Change In Payable: 612961.00
BAYA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 911226.00
BAYA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 205666.00
BAYA cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 23011.00
BAYA cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 16847.00
BAYA cash_flow (annual, 2025-12-31) — Change In Working Capital: 934237.00
BAYA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 222513.00
BAYA cash_flow (annual, 2025-12-31) — Changes In Cash: -49491.00
BAYA cash_flow (quarterly, 2025-12-31) — Changes In Cash: 5787.00
BAYA balance_sheet (annual, 2025-12-31) — Common Stock: 11761163.00
BAYA balance_sheet (quarterly, 2025-12-31) — Common Stock: 11761163.00
BAYA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 6246336.00
BAYA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 6246336.00
BAYA cash_flow (annual, 2025-12-31) — Common Stock Payments: -30283157.00
BAYA cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -8456656.00
BAYA balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 842103.00
BAYA balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 842103.00
BAYA balance_sheet (annual, 2025-12-31) — Current Assets: 52465.00
BAYA balance_sheet (quarterly, 2025-12-31) — Current Assets: 52465.00
BAYA balance_sheet (annual, 2025-12-31) — Current Debt: 1775000.00
BAYA balance_sheet (quarterly, 2025-12-31) — Current Debt: 1775000.00
BAYA balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1775000.00
BAYA balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1775000.00
BAYA balance_sheet (annual, 2025-12-31) — Current Liabilities: 3467119.00
BAYA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 3467119.00
BAYA balance_sheet (annual, 2025-12-31) — Current Notes Payable: 1775000.00
BAYA balance_sheet (quarterly, 2025-12-31) — Current Notes Payable: 1775000.00
BAYA income_statement (annual, 2025-12-31) — Diluted Average Shares: 4354330.00
BAYA income_statement (annual, 2025-12-31) — Diluted EPS: 0.05
BAYA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 202599.00
BAYA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -37574.00
BAYA balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 180705.00
BAYA balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 180705.00
BAYA income_statement (annual, 2025-12-31) — EBIT: -986503.00
BAYA income_statement (quarterly, 2025-12-31) — EBIT: -217212.00
BAYA income_statement (annual, 2025-12-31) — EBITDA: -986503.00
BAYA income_statement (quarterly, 2025-12-31) — EBITDA: -217212.00
BAYA cash_flow (annual, 2025-12-31) — End Cash Position: 44129.00
BAYA cash_flow (quarterly, 2025-12-31) — End Cash Position: 44129.00
BAYA cash_flow (annual, 2025-12-31) — Financing Cash Flow: -29008157.00
BAYA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -8206656.00
BAYA cash_flow (annual, 2025-12-31) — Free Cash Flow: -49491.00
BAYA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 5787.00
BAYA cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -1186327.00
BAYA cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -179152.00
BAYA income_statement (annual, 2025-12-31) — Interest Income: 1189102.00
BAYA income_statement (quarterly, 2025-12-31) — Interest Income: 179638.00
BAYA income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1189102.00
BAYA income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 179638.00
BAYA balance_sheet (annual, 2025-12-31) — Invested Capital: 8021336.00
BAYA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 8021336.00
BAYA cash_flow (annual, 2025-12-31) — Investing Cash Flow: 29008157.00
BAYA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 8206656.00
BAYA cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1275000.00
BAYA cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 250000.00
BAYA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -30283157.00
BAYA cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -8456656.00
BAYA balance_sheet (annual, 2025-12-31) — Net Debt: 1730871.00
BAYA balance_sheet (quarterly, 2025-12-31) — Net Debt: 1730871.00
BAYA income_statement (annual, 2025-12-31) — Net Income: 202599.00
BAYA income_statement (quarterly, 2025-12-31) — Net Income: -37574.00
BAYA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 202599.00
BAYA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -37574.00
BAYA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 202599.00
BAYA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -37574.00
BAYA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 202599.00
BAYA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -37574.00
BAYA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 202599.00
BAYA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -37574.00
BAYA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 202599.00
BAYA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -37574.00
BAYA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 202599.00
BAYA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -37574.00
BAYA income_statement (annual, 2025-12-31) — Net Interest Income: 1189102.00
BAYA income_statement (quarterly, 2025-12-31) — Net Interest Income: 179638.00
BAYA cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 1275000.00
BAYA cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 250000.00
BAYA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 1189102.00
BAYA income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 179638.00
BAYA cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 29008157.00
BAYA cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 8206656.00
BAYA cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 1275000.00
BAYA cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 250000.00
BAYA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 6246336.00
BAYA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 6246336.00
BAYA income_statement (annual, 2025-12-31) — Normalized EBITDA: -986503.00
BAYA income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -217212.00
BAYA income_statement (annual, 2025-12-31) — Normalized Income: 202599.00
BAYA income_statement (quarterly, 2025-12-31) — Normalized Income: -37574.00
BAYA cash_flow (annual, 2025-12-31) — Operating Cash Flow: -49491.00
BAYA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 5787.00
BAYA cash_flow (annual, 2025-12-31) — Operating Gains Losses: -1186327.00
BAYA cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -179152.00
BAYA income_statement (annual, 2025-12-31) — Operating Income: -986503.00
BAYA income_statement (quarterly, 2025-12-31) — Operating Income: -217212.00
BAYA income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
BAYA income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
BAYA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 2738292.00
BAYA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 2738292.00
BAYA balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 11760990.00
BAYA balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 11760990.00
BAYA income_statement (annual, 2025-12-31) — Other Operating Expenses: 986503.00
BAYA income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 217212.00
BAYA balance_sheet (annual, 2025-12-31) — Other Payable: 669311.00
BAYA balance_sheet (quarterly, 2025-12-31) — Other Payable: 669311.00
BAYA balance_sheet (annual, 2025-12-31) — Payables: 850016.00
BAYA balance_sheet (quarterly, 2025-12-31) — Payables: 850016.00
BAYA balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1692119.00
BAYA balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1692119.00
BAYA balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
BAYA balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
BAYA balance_sheet (annual, 2025-12-31) — Prepaid Assets: 8336.00
BAYA balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 8336.00
BAYA income_statement (annual, 2025-12-31) — Pretax Income: 202599.00
BAYA income_statement (quarterly, 2025-12-31) — Pretax Income: -37574.00
BAYA cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -30283157.00
BAYA cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -8456656.00
BAYA balance_sheet (annual, 2025-12-31) — Retained Earnings: -5514827.00
BAYA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -5514827.00
BAYA balance_sheet (annual, 2025-12-31) — Share Issued: 2738292.00
BAYA balance_sheet (quarterly, 2025-12-31) — Share Issued: 2738292.00
BAYA cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 1275000.00
BAYA cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 250000.00
BAYA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 6246336.00
BAYA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 6246336.00
BAYA balance_sheet (annual, 2025-12-31) — Tangible Book Value: 6246336.00
BAYA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 6246336.00
BAYA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BAYA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BAYA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
BAYA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
BAYA balance_sheet (annual, 2025-12-31) — Total Assets: 11813455.00
BAYA balance_sheet (quarterly, 2025-12-31) — Total Assets: 11813455.00
BAYA balance_sheet (annual, 2025-12-31) — Total Capitalization: 6246336.00
BAYA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 6246336.00
BAYA balance_sheet (annual, 2025-12-31) — Total Debt: 1775000.00
BAYA balance_sheet (quarterly, 2025-12-31) — Total Debt: 1775000.00
BAYA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 6246336.00
BAYA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 6246336.00
BAYA income_statement (annual, 2025-12-31) — Total Expenses: 986503.00
BAYA income_statement (quarterly, 2025-12-31) — Total Expenses: 217212.00
BAYA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 5567119.00
BAYA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 5567119.00
BAYA balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 11760990.00
BAYA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 11760990.00
BAYA balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2100000.00
BAYA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2100000.00
BAYA income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -986503.00
BAYA income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -217212.00
BAYA balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 2100000.00
BAYA balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 2100000.00
BAYA balance_sheet (annual, 2025-12-31) — Working Capital: -3414654.00
BAYA balance_sheet (quarterly, 2025-12-31) — Working Capital: -3414654.00
BAYA income_statement (quarterly, 2026-03-31) — +Operating Expense: 471513.00
BAYA income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
BAYA balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 0.00
BAYA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 2738292.00
BAYA income_statement (quarterly, 2026-03-31) — Basic EPS: -0.13
BAYA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 44129.00
BAYA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 12014919.00
BAYA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 50187.00
BAYA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 50187.00
BAYA balance_sheet (quarterly, 2026-03-31) — Cash Financial: 50187.00
BAYA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 150000.00
BAYA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -150000.00
BAYA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 6058.00
BAYA cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 148694.00
BAYA cash_flow (quarterly, 2026-03-31) — Change In Payable: 396355.00
BAYA cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 545049.00
BAYA cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -67891.00
BAYA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 477158.00
BAYA cash_flow (quarterly, 2026-03-31) — Changes In Cash: 6058.00
BAYA balance_sheet (quarterly, 2026-03-31) — Common Stock: 12014919.00
BAYA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 5878992.00
BAYA balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 990797.00
BAYA balance_sheet (quarterly, 2026-03-31) — Current Assets: 126414.00
BAYA balance_sheet (quarterly, 2026-03-31) — Current Debt: 1925000.00
BAYA balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1925000.00
BAYA balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4162168.00
BAYA balance_sheet (quarterly, 2026-03-31) — Current Notes Payable: 1925000.00
BAYA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 2738292.00
BAYA income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.13
BAYA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -367344.00
BAYA balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 210938.00
BAYA income_statement (quarterly, 2026-03-31) — EBIT: -471513.00
BAYA income_statement (quarterly, 2026-03-31) — EBITDA: -471513.00
BAYA cash_flow (quarterly, 2026-03-31) — End Cash Position: 50187.00
BAYA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 150000.00
BAYA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 6058.00
BAYA cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -103756.00
BAYA income_statement (quarterly, 2026-03-31) — Interest Income: 104169.00
BAYA income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 104169.00
BAYA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 7803992.00
BAYA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -150000.00
BAYA cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 150000.00
BAYA balance_sheet (quarterly, 2026-03-31) — Net Debt: 1874813.00
BAYA income_statement (quarterly, 2026-03-31) — Net Income: -367344.00
BAYA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -367344.00
BAYA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -367344.00
BAYA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -367344.00
BAYA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -367344.00
BAYA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -367344.00
BAYA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -367344.00
BAYA income_statement (quarterly, 2026-03-31) — Net Interest Income: 104169.00
BAYA cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 150000.00
BAYA income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 104169.00
BAYA cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -150000.00
BAYA cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 150000.00
BAYA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5878992.00
BAYA income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -471513.00
BAYA income_statement (quarterly, 2026-03-31) — Normalized Income: -367344.00
BAYA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 6058.00
BAYA cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -103756.00
BAYA income_statement (quarterly, 2026-03-31) — Operating Income: -471513.00
BAYA income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
BAYA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 2738292.00
BAYA balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 12014746.00
BAYA income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 471513.00
BAYA balance_sheet (quarterly, 2026-03-31) — Other Payable: 1035433.00
BAYA balance_sheet (quarterly, 2026-03-31) — Payables: 1246371.00
BAYA balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 2237168.00
BAYA balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
BAYA balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 76227.00
BAYA income_statement (quarterly, 2026-03-31) — Pretax Income: -367344.00
BAYA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -6135927.00
BAYA balance_sheet (quarterly, 2026-03-31) — Share Issued: 2738292.00
BAYA cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 150000.00
BAYA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5878992.00
BAYA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5878992.00
BAYA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BAYA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
BAYA balance_sheet (quarterly, 2026-03-31) — Total Assets: 12141160.00
BAYA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 5878992.00
BAYA balance_sheet (quarterly, 2026-03-31) — Total Debt: 1925000.00
BAYA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5878992.00
BAYA income_statement (quarterly, 2026-03-31) — Total Expenses: 471513.00
BAYA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 6262168.00
BAYA balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 12014746.00
BAYA balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2100000.00
BAYA income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -471513.00
BAYA balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 2100000.00
BAYA balance_sheet (quarterly, 2026-03-31) — Working Capital: -4035754.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -2619000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 1446000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -46000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Amortization: 7000000.00
BAYERCROP.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 7000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 44942092.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Basic EPS: 143.58
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 2829000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 7274000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 535000000.00
BAYERCROP.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -6728000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 159000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 44942092.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Diluted EPS: 143.58
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 58000000.00
BAYERCROP.NS cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 0.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 5873000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 1030000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 10093000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 17000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Interest Income: 245000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 245000000.00
BAYERCROP.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 0.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 328000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 3196000000.00
BAYERCROP.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 614000000.00
BAYERCROP.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 0.00
BAYERCROP.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 0.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 0.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 752000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 322000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 722000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Other Payable: 2785000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 98000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Other Special Charges: -579000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1098000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1613000000.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 6353000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 114000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 114000000.00
BAYERCROP.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: 0.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 65000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Restructuring And Mergern Acquisition: 0.00
BAYERCROP.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 20465000000.00
BAYERCROP.NS cash_flow (annual, 2022-03-31) — Sale Of Business: 614000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 4295000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 5325000000.00
BAYERCROP.NS cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 0.00
BAYERCROP.NS cash_flow (annual, 2022-03-31) — Short Term Debt Payments: 0.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Special Income Charges: 509000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Total Unusual Items: 603000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 603000000.00
BAYERCROP.NS income_statement (annual, 2022-03-31) — Write Off: 53000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — +Operating Expense: 12334000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — +Total Revenue: 49449000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 8732000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 9756000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -3160000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 1446000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -34000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Amortization: 15000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 15000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 54000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 44942092.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Basic EPS: 168.71
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 7809000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 2976000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -773000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 735000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 449000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 8608000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 9019000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -5611000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 7906000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 702000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -3579000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 298000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 807000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Change In Payable: 533000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 313000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -1409000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 794000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Common Stock: 449000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -5611000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 27121000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 76000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 28517000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Current Assets: 38964000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 371000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 371000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 29000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 17775000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 1130000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Depreciation: 780000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 795000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 795000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 780000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 44942092.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Diluted EPS: 168.71
BAYERCROP.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 7582000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 65000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — EBIT: 10124000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — EBITDA: 10919000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — End Cash Position: 8603000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -6132000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 5860000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 5320000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -135000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -4000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 1290000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 1147000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 9790000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 7520000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Gross Profit: 20932000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 1000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Interest Expense: 223000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 223000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Interest Income: 340000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 340000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -112000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 252000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Inventory: 18072000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 27121000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 833000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 256000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 54000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 314000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 364000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 364000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 442000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 3479000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 1111000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 8000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Net Income: 7582000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 7582000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 7582000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 7582000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 7582000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 9901000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 7582000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Net Interest Income: 117000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 104000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 117000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 92000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Net PPE: 4360000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -726000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 25974000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 3000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1081000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 291000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 9832000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Normalized Income: 6749595798.40
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 6093000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Operating Income: 8598000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Operating Revenue: 49449000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 44942092.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 578000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 1191000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 26672000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 1147000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 797000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -1232000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 284000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 121000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 2403000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Other Payable: 3024000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Other Properties: 675000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 39000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 411000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Other Special Charges: -1043000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Payables: 11821000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1130000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 1428000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Pretax Income: 9901000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -40000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -773000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 9216000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 28517000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 795000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 120000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 120000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 72000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 21698000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 1111000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 104000000.00
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 47000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 4215000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 5505000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Share Issued: 44942092.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Special Income Charges: 952000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 27121000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 25974000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 254595798.40
BAYERCROP.NS income_statement (annual, 2023-03-31) — Tax Provision: 2319000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.23
BAYERCROP.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -2395000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Total Assets: 46786000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 27121000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Total Debt: 735000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 27121000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Total Expenses: 40851000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 19665000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 7822000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 1890000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 29000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 1087000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 1087000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Work In Process: 2199000000.00
BAYERCROP.NS balance_sheet (annual, 2023-03-31) — Working Capital: 21189000000.00
BAYERCROP.NS income_statement (annual, 2023-03-31) — Write Off: 90000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — +Operating Expense: 10405000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — +Total Revenue: 48921000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 6051000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 9601000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -3579000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 1446000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -62000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Amortization: 19000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 19000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 72000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 44942092.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Basic EPS: 164.77
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 8608000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 3003000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -457000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 471000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 449000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 11568000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 12107000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -6067000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 10228000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 1340000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 2072000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 170000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 1577000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Change In Payable: -2681000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 129000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 339000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 2957000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Common Stock: 449000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -6067000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 28494000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 86000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 29431000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Current Assets: 39055000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 261000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 261000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 19000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 15974000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 518000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Depreciation: 721000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 740000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 740000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 721000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 44942092.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Diluted EPS: 164.77
BAYERCROP.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 7405000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 65000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — EBIT: 9610000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — EBITDA: 10350000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — End Cash Position: 11565000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -6563000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 5427000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 9059000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -148000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 60000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 1468000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 1254000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 9663000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 7427000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Gross Profit: 19490000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 191000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Interest Expense: 196000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 196000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Interest Income: 484000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 484000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -112000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 304000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Inventory: 15452000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 28494000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: 4000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 251000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 72000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 314000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 210000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 210000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 1253000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 3554000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -3000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Net Income: 7405000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 7405000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 7405000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 7405000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 7405000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 9414000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 7405000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Net Interest Income: 288000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 17000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 288000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 77000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Net PPE: 3848000000.00
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -394000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 27240000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 0.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 40000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 776000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 363000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 10455000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Normalized Income: 7487592415.55
BAYERCROP.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 9516000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Operating Income: 9085000000.00
BAYERCROP.NS income_statement (annual, 2024-03-31) — Operating Revenue: 48921000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 44942092.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 372000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 866000000.00
BAYERCROP.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 28045000000.00